Released on = July 27, 2007, 11:08 am

Press Release Author = AnaSpec Inc.

Industry = Biotech

Press Release Summary = Reporting on results gathered from its antibody and assay
kit departments, AnaSpec has released data that supports the efficacy of its
MOG(35-55) peptide.

Press Release Body = July 25, 2007 - San Jose, CA

Reporting on results gathered from its antibody and assay kit departments, AnaSpec
has released data that supports the efficacy of its MOG(35-55) peptide.

Analytical results reported the following:

AnaSpec's mouse/rat MOG(35-55) peptide induced EAE in C57BL/6 mice with 100%
incident (10/10). These results provide quantitative support for the suitability of
the MOG peptide for in vivo EAE study. Experimental autoimmune encephalomyelitis
(EAE) is an in vivo animal model for multiple sclerosis (MS) pathogenesis.

AnaSpec's mouse/rat MOG(35-55) peptide induced anti-MOG(35-55) autoantibody
production in C57BL/6 mice with 100% incident (10/10). These results provide
quantitative support for the suitability of the MOG peptide for in vivo
anti-MOG(35-55) autoantibody study.

AnaSpec's mouse/rat MOG(35-55) peptide induced polyclonal anti-MOG(35-55) antibody
production in rabbits with high specificity, high affinity, and high titer (>3125K)
indicating the high purity of AnaSpec's MOG peptide as well as suitability for
peptide-coated ELISA and Western blot assay.

Using AnaSpec's mouse/rat MOG(35-55) peptide as a coating peptide, AnaSpec produced
the industry's first anti-MOG (35-55) ELISA kit for EAE study. The detection limit
was measured to be as low as 50 pg of anti-MOG (35-55) autoantibody in serum or
cerebrospinal fluid. After testing different lots of AnaSpec MOG peptides for ELISA
coating, AnaSpec reported that the quality variation from lot to lot was minimal.

Company Info
AnaSpec, Inc. is a leading provider of integrated proteomics solutions to
pharmaceutical, biotech, and academic research institutions throughout the world.
With a vision for innovation through synergy, AnaSpec focuses on three core
technologies: peptides, detection reagents, and combinatorial chemistry.
Established in 1993, AnaSpec\'s headquarters and manufacturing facilities are located
in San Jose, CA.

For more information visit www.anaspec.com


Web Site = http://www.anaspec.com

Contact Details = 2149 O\'toole Ave.
San Jose, CA 95131
ping@anaspec.com
1-408-452-5055